Bifogade filer
a4feec3c-84ad-4bec-b2e1-e467204eb501
Kurs
-2,33%
Kurs
-2,33%
Open
5,55
High
5,69
Low
5,36
Close
5,45
Kursutveckling under dagen för detta pressmeddelande
(NOK).
Likviditet
15,9 MNOK
Likviditet
15,9 MNOK
Rel. mcap
0,89%
Antal aktier
2 902 901
Likviditet under dagen för detta pressmeddelande
Kalender
| Est. tid* | ||
| 2026-08-28 | 08:00 | Kvartalsrapport 2026-Q2 |
| 2026-04-24 | N/A | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2026-04-23 | N/A | Årsstämma |
| 2026-02-26 | - | Bokslutskommuniké 2025 |
| 2025-08-29 | - | Kvartalsrapport 2025-Q2 |
| 2025-04-25 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2025-04-24 | - | Årsstämma |
| 2025-02-26 | - | Bokslutskommuniké 2024 |
| 2025-01-06 | - | Extra Bolagsstämma 2025 |
| 2024-08-30 | - | Kvartalsrapport 2024-Q2 |
| 2024-04-12 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2024-04-11 | - | Årsstämma |
| 2024-02-28 | - | Bokslutskommuniké 2023 |
| 2023-08-31 | - | Kvartalsrapport 2023-Q2 |
| 2023-04-27 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2023-04-26 | - | Årsstämma |
| 2023-02-28 | - | Bokslutskommuniké 2022 |
| 2022-08-31 | - | Kvartalsrapport 2022-Q2 |
| 2022-04-29 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2022-04-28 | - | Årsstämma |
| 2022-03-01 | - | Bokslutskommuniké 2021 |
| 2021-11-18 | - | 15-10 2021-Q3 |
| 2021-08-26 | - | Kvartalsrapport 2021-Q2 |
| 2021-05-26 | - | Kvartalsrapport 2021-Q1 |
| 2021-04-28 | - | Årsstämma |
| 2021-04-16 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2021-03-22 | - | Extra Bolagsstämma 2021 |
| 2021-02-18 | - | Bokslutskommuniké 2020 |
| 2020-11-19 | - | Kvartalsrapport 2020-Q3 |
| 2020-10-21 | - | Extra Bolagsstämma 2020 |
| 2020-08-27 | - | Kvartalsrapport 2020-Q2 |
| 2020-06-11 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2020-06-10 | - | Årsstämma |
| 2020-05-26 | - | Kvartalsrapport 2020-Q1 |
| 2020-02-27 | - | Bokslutskommuniké 2019 |
| 2019-11-19 | - | Kvartalsrapport 2019-Q3 |
| 2019-08-22 | - | Kvartalsrapport 2019-Q2 |
| 2019-05-23 | - | Kvartalsrapport 2019-Q1 |
| 2019-04-26 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2019-04-25 | - | Årsstämma |
| 2019-02-18 | - | Extra Bolagsstämma 2019 |
| 2018-08-22 | - | Kvartalsrapport 2018-Q2 |
| 2018-05-31 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2018-05-30 | - | Årsstämma |
| 2018-05-30 | - | Kvartalsrapport 2018-Q1 |
| 2018-02-27 | - | Bokslutskommuniké 2017 |
| 2017-12-20 | - | Extra Bolagsstämma 2017 |
| 2017-11-22 | - | Kvartalsrapport 2017-Q3 |
| 2017-08-23 | - | Kvartalsrapport 2017-Q2 |
| 2017-05-26 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2017-05-24 | - | Årsstämma |
| 2017-05-24 | - | Kvartalsrapport 2017-Q1 |
| 2017-02-28 | - | Bokslutskommuniké 2016 |
| 2016-11-23 | - | Kvartalsrapport 2016-Q3 |
| 2016-10-12 | - | Extra Bolagsstämma 2016 |
| 2016-08-24 | - | Kvartalsrapport 2016-Q2 |
| 2016-05-31 | - | Kapitalmarknadsdag 2016 |
| 2016-05-20 | - | X-dag ordinarie utdelning TRMED 0.00 NOK |
| 2016-05-19 | - | Årsstämma |
| 2016-05-19 | - | Kvartalsrapport 2016-Q1 |
| 2016-02-26 | - | Bokslutskommuniké 2015 |
| 2015-11-17 | - | Kapitalmarknadsdag 2015 |
| 2015-10-21 | - | Kvartalsrapport 2015-Q3 |
| 2015-08-26 | - | Kvartalsrapport 2015-Q2 |
| 2015-05-27 | - | Kvartalsrapport 2015-Q1 |
| 2015-03-09 | - | Årsstämma |
| 2014-11-12 | - | Extra Bolagsstämma 2014 |
Beskrivning
| Land | Norge |
|---|---|
| Lista | Oslo Bors |
| Sektor | Hälsovård |
| Industri | Läkemedel & Handel |
Intresserad av bolagets nyckeltal?
Analysera bolaget i Börsdata!
Vem äger bolaget?
All ägardata du vill ha finns i Holdings!
2026-04-10 09:51:28
10.4.2026 09:51:08 CEST | Thor Medical ASA | Additional regulated information
required to be disclosed under the laws of a member state
9 April 2026 | Thor Medical ASA | Additional regulated information required to
be disclosed under the laws of a member state
The nomination committee has made its recommendation to the Annual General
Meeting of Thor Medical ASA that will be held on 23 April 2026, at 14:00 hours
CEST at Advokatfirmaet Selmer, Ruseløkkveien 14, 0251 Oslo. The recommendation
and the previously distributed notice are not fully aligned, and the company
wishes to clarify that the proposed resolutions for the general meeting are as
set out in the nomination committee's recommendation with respect to the matters
it concerns.
The recommendation of the nomination committee is attached and is also available
on www.thormedical.com - https://www.thormedical.com.
For further information please contact:
Mathias Nilsen Reierth
Head of Communications and Corporate Affairs
Tel: +47 988 05 724
mathias.reierth@thormedical.com
ABOUT THOR MEDICAL ASA
Thor Medical is an emerging supplier of radionuclides, primarily alpha particle
emitters, from naturally occurring thorium. Its proprietary production process
requires no irradiation or use of nuclear reactors, and provides reliable,
environmentally friendly, cost-efficient supply of alpha-emitters for the
radiopharmaceutical industry. Thor Medical is headquartered in Oslo, Norway and
listed on the Oslo Stock Exchange under the ticker symbol 'TRMED'.
To learn more, visit www.thormedical.com - http://www.thormedical.com
DISCLOSURE REGULATION
This information is required to be disclosed under Section 5-12 of the
Securities Trading Act.
ATTACHMENTS
a4feec3c-84ad-4bec-b2e1-e467204eb501.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18858270/7031/a4feec3c-84ad-4bec-
b2e1-e467204eb501.pdf
Thor Medical - Nomination Committee proposal 2026.pdf -
https://kommunikasjon.ntb.no/ir-files/17848634/18858270/7030/Thor%20Medical%20-%
20Nomination%20Committee%20proposal%202026.pdf